Aneugenic and clastogenic effects of doxorubicin in human lymphocytes

被引:53
作者
Dhawan, A
Kayani, MA
Parry, JM
Parry, E
Anderson, D [2 ]
机构
[1] Ind Toxicol Res Ctr, Lucknow 226001, Uttar Pradesh, India
[2] Univ Bradford, Dept Biomed Sci, Bradford BD7 1DP, W Yorkshire, England
[3] Univ Coll Swansea, Ctr Mol Genet & Toxicol, Swansea SA2 8PP, W Glam, Wales
关键词
D O I
10.1093/mutage/geg024
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Doxorubicin, a benzanthroquinone anticancer agent, was examined for its effect on micronucleus induction in cultured human lymphocytes. A statistically significant dose-dependent increase in micronucleus frequency (P < 0.001) in binucleated cells was seen and an increase in the kinetochore-positive (P < 0.001) and kinetochore-negative micronuclei (P < 0.001) was observed. An increase was also observed in the number of necrotic cells, but the frequency of apoptotic cells remained almost constant. This confirms that doxorubicin is both clastogenic and aneugenic.
引用
收藏
页码:487 / 490
页数:4
相关论文
共 22 条
[1]   DNA-BASE MODIFICATIONS INDUCED IN ISOLATED HUMAN CHROMATIN BY NADH DEHYDROGENASE-CATALYZED REDUCTION OF DOXORUBICIN [J].
AKMAN, SA ;
DOROSHOW, JH ;
BURKE, TG ;
DIZDAROGLU, M .
BIOCHEMISTRY, 1992, 31 (13) :3500-3506
[2]  
Aly MS, 1999, ENVIRON MOL MUTAGEN, V33, P161, DOI 10.1002/(SICI)1098-2280(1999)33:2<161::AID-EM8>3.0.CO
[3]  
2-M
[4]   Protective effects of alpha-hederin, chlorophyllin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes [J].
AmaraMokrane, YA ;
LehucherMichel, MP ;
Balansard, G ;
Dumenil, G ;
Botta, A .
MUTAGENESIS, 1996, 11 (02) :161-167
[5]   The use of the same image analysis system to detect genetic damage in human lymphocytes treated with doxorubicin in the Comet and fluoresence in situ hybridisation (FISH) assays [J].
Anderson, D ;
Yu, TW ;
Browne, MA .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 390 (1-2) :69-77
[6]  
[Anonymous], 2000, GUID STRAT TEST CHEM
[7]   INVITRO MICRONUCLEUS BIOASSAY OF HUMAN PERIPHERAL LYMPHOCYTES FOR ADRIAMYCIN IN THE PRESENCE OF CYCLOPHOSPHAMIDE AND URINES OF PATIENTS ADMINISTERED ANTICANCER DRUGS [J].
BOUCHER, R ;
LIVINGSTON, GK ;
HEE, SSQ .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1993, 21 (04) :372-382
[8]   Cytochrome P450 1A1 (CYP1A1) in blood lymphocytes - Evidence for catalytic activity and mRNA expression [J].
Dey, A ;
Parmar, D ;
Dayal, M ;
Dhawan, A ;
Seth, PK .
LIFE SCIENCES, 2001, 69 (04) :383-393
[9]  
Duffaud F, 1998, ANN BIOL CLIN-PARIS, V56, P183
[10]   THE USE OF GENETICALLY ENGINEERED V79 CHINESE-HAMSTER CULTURES EXPRESSING RAT-LIVER CYP1A1, 1A2 AND 2B1 CDNAS IN MICRONUCLEUS ASSAYS [J].
ELLARD, S ;
MOHAMMED, Y ;
DOGRA, S ;
WOLFEL, C ;
DOEHMER, J ;
PARRY, JM .
MUTAGENESIS, 1991, 6 (06) :461-470